San Francisco Serenade - Healthcare Conference - Kieger
icon-menu-open Created with Sketch.
icon-menu-close Created with Sketch.
Kieger
icon-arrow Created with Sketch. icon-arrow Created with Sketch.
News
icon-arrow Created with Sketch. icon-arrow Created with Sketch.
San Francisco Serenade - Healthcare Conference

San Francisco Serenade - Healthcare Conference

Kieger’s top takeaways on the JP Morgan Healthcare Conference

We recently attended the 41st J.P. Morgan Healthcare Conference in San Francisco, which took place from January 9th to January 12th 2023. Our overall conclusion from the conference is that the industry remains in good shape. The key themes that emerged during the week from a devices and services perspective were, the rise of value-based care and innovation & digitalisation. However, it also became clear that the macroeconomic environment is still the dominant force behind (sub) sector performance.

The investment year 2022 was not only eventful but for many also painful. While still negative, in the end,
Healthcare outperformed the market by 12.7% (MSCI World Healthcare NT vs. MSCI World NT), once again showing its resilience. To get a better understanding of 2023, healthcare executives, investors and other stakeholder groups again travelled west and made San Francisco the centre of attention of the industry, at least for a week. Pre pandemic this conference used to be extremely crowded, to the extent that sometimes it was impossible to pass through the hallways. With organisational adjustments it was slightly less full but still very well attended. The conference continues to serve as a platform for previewing full year results, meeting competitors, and occasionally announcing M&A transactions and strategy updates. Click on the link below, and find out about our key conference takeaways.

Related News

Healthcare
7. June 2023

ASCO – American Society of Clinical Oncology Conference

We attended the ASCO 2023 annual meeting in Chicago. After the rise of immuno-oncology, COVID-19 challenged clinical trial execution and muted patient numbers. In the last years we saw many setbacks of once promising immuno-oncology combinations trials.

Healthcare
1. June 2023

Kieger Healthcare Monthly Commentary

What mattered this month in healthcare? Q1 reporting came to a close, and FTC action put pressure on the biopharma space and... Find out more in our monthly healthcare newsletter.

Healthcare
25. May 2023

Kieger Healthcare Chart of the Month

With M&A picking up, are we at a turning point for biotech? Check out our latest Kieger AG Chart of the Month Video.

Contact

icon-menu-close Created with Sketch.

Get in contact with us by using the form below or via telephone. We look forward to hearing from you.

Something is wrong
Something is wrong
Something is wrong
Something is wrong
Something is wrong
Something is wrong
Something is wrong
Something went wrong. Try again later.

Thank you!

Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Donec quam felis, ultricies nec, pellentesque eu, pretium quis, sem.

Kieger jobs

icon-menu-close Created with Sketch.

There are no job vacancies at the moment.